Cite

HARVARD Citation

    Petracci, E. et al. (2020). Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial. Therapeutic advances in medical oncology. p. . [Online]. 
  
Back to record